Revenue
attach_money23M USD
YoY -50.6%
NAMSWNewAmsterdam Pharma Company N.V.$ --
NewAmsterdam Pharma Company N.V.
NAMSW
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-226M USD
YoY -28.0%
Net Income
verified-204M USD
YoY +15.6%
EPS
pie_chart-1.75USD
YoY +31.6%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress103.4%On Track
Revenue Progress22.5M
Revenue Forecast24M
Net Income Progress-203.8M
Net Income Forecast-197.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.